Science Explorer Back to mapMap
Discussion

Biota Pharmaceuticals (United States)

Research works
111
▲ 116% vs 2018-21
Citations
1.6k
14.0 per fractional work
Top-10% rate
8.2%
all institutions 10.0%
Open access
52%
world 40%
International
36%
world 18%

Not ranked overall: Biota Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Biota Pharmaceuticals (United States) work in?

In 2022-now, 41% of research at Biota Pharmaceuticals (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (24%), Environmental Science (8%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 17 fractional works · 41.0% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 24.3% of its workMolecular Biology: 6 fractional works · 14.4% of its workGenetics: 2 fractional works · 4.1% of its workCancer Research: 1 fractional works · 2.8% of its workCell Biology: 1 fractional works · 1.4% of its workBiotechnology: 0 fractional works · 0.9% of its workMolecular Medicine: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 3 fractional works · 7.5% of its workPlant Science: 1 fractional works · 3.2% of its workGeneral Agricultural and Biological Sciences: 1 fractional works · 1.6% of its workAnimal Science and Zoology: 0 fractional works · 0.9% of its workFood Science: 0 fractional works · 0.6% of its workAgronomy and Crop Science: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workInsect Science: 0 fractional works · 0.4% of its workImmunology and Microbiology: 2 fractional works · 5.4% of its workImmunology: 2 fractional works · 4.6% of its workMicrobiology: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.3% of its workPharmacology: 1 fractional works · 1.3% of its workPharmaceutical Science: 1 fractional works · 1.2% of its workToxicology: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 0.6% of its workSensory Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Sciences: 15 fractional works · 36.2% of its workMedicine: 15 fractional works · 34.4% of its workDermatology: 2 fractional works · 5.2% of its workOncology: 2 fractional works · 4.1% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.3% of its workInfectious Diseases: 1 fractional works · 2.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.9% of its workComplementary and alternative medicine: 1 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workEpidemiology: 1 fractional works · 1.2% of its workUrology: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workHepatology: 0 fractional works · 0.8% of its workRehabilitation: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.9% of its workNursing: 1 fractional works · 1.6% of its workNutrition and Dietetics: 1 fractional works · 1.6% of its workDentistry: 0 fractional works · 0.2% of its workPhysical Sciences: 8 fractional works · 19.5% of its workEnvironmental Science: 4 fractional works · 8.4% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 2.7% of its workEcology: 0 fractional works · 1.1% of its workEcological Modeling: 0 fractional works · 1.0% of its workWater Science and Technology: 0 fractional works · 0.9% of its workEnvironmental Chemistry: 0 fractional works · 0.8% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.7% of its workEnvironmental Engineering: 0 fractional works · 0.4% of its workGlobal and Planetary Change: 0 fractional works · 0.4% of its workPollution: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 2 fractional works · 5.4% of its workBiomedical Engineering: 1 fractional works · 1.6% of its workMechanical Engineering: 1 fractional works · 1.4% of its workAerospace Engineering: 0 fractional works · 1.2% of its workBuilding and Construction: 0 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 2.1% of its workInformation Systems: 1 fractional works · 1.6% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workChemistry: 1 fractional works · 1.8% of its workOrganic Chemistry: 1 fractional works · 1.3% of its workAnalytical Chemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.8% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.8% of its workEarth and Planetary Sciences: 0 fractional works · 0.4% of its workPaleontology: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workChemical Engineering: 0 fractional works · 0.2% of its workCatalysis: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 3.3% of its workSocial Sciences: 1 fractional works · 1.4% of its workSociology and Political Science: 0 fractional works · 0.8% of its workPolitical Science and International Relations: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.2% of its workEconomics and Econometrics: 0 fractional works · 1.0% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.4% of its workManagement Science and Operations Research: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.3% of its workALL ITS WORKBiotaPharmaceuticals…43fractional works, 2022-now
Life Sciences41%Physical Sciences19%Health Sciences36%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1024.3%
    2. Agricultural and Biological Sciences37.5%
    3. Immunology and Microbiology25.4%
    4. Pharmacology, Toxicology and Pharmaceutics13.3%
    5. Neuroscience00.6%
    1. Medicine1534.4%
    2. Nursing11.6%
    3. Dentistry00.2%
    1. Environmental Science48.4%
    2. Engineering25.4%
    3. Computer Science12.1%
    4. Chemistry11.8%
    5. Energy00.8%
    6. Earth and Planetary Sciences00.4%
    7. Materials Science00.4%
    8. Chemical Engineering00.2%
    1. Social Sciences11.4%
    2. Economics, Econometrics and Finance11.2%
    3. Decision Sciences00.4%
    4. Psychology00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.59× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.55× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 5.35× its world share, 2 worksImmunology and Micro…Neuroscience: 0.34× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.40× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.67× its world share, 0 worksChemical EngineeringChemistry: 1.15× its world share, 1 worksChemistryComputer Science: 0.27× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.27× its world share, 0 worksEarth and Planetary …Energy: 0.88× its world share, 0 worksEnergyEngineering: 0.36× its world share, 2 worksEngineeringEnvironmental Science: 1.69× its world share, 4 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 0 worksMaterials ScienceDentistry: 0.32× its world share, 0 worksDentistryMedicine: 1.79× its world share, 15 worksMedicineNursing: 3.19× its world share, 1 worksNursingDecision Sciences: 0.40× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.58× its world share, 0 worksEconomics, Econometr…Psychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.11× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.4×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.40×1 works
  2. Immunology and Microbiology5.35×2 works
  3. Biochemistry, Genetics and Molecular Biology4.55×10 works
  4. Nursing3.19×1 works
  5. Medicine1.79×15 works
  6. Environmental Science1.69×4 works
  7. Agricultural and Biological Sciences1.59×3 works
  8. Chemistry1.15×1 works
  9. Energy0.88×0 works
  10. Chemical Engineering0.67×0 works
  11. Economics, Econometrics and Finance0.58×0 works
  12. Decision Sciences0.40×0 works
  13. Engineering0.36×2 works
  14. Neuroscience0.34×0 works
  15. Dentistry0.32×0 works
  16. Computer Science0.27×1 works
  17. Earth and Planetary Sciences0.27×0 works
  18. Social Sciences0.11×1 works
  19. Materials Science0.10×0 works
  20. Psychology0.08×0 works

Who are the top researchers at Biota Pharmaceuticals (United States)?

Ranked on the quality score, Jennifer L. Brooks, Patrick C. Fagan and Thomas W. Bruice lead among researchers whose main affiliation is Biota Pharmaceuticals (United States).

  1. 1 Jennifer L. Brooks United States · #1,287,983 worldwide 1.5k citations · 40 works
  2. 2 Patrick C. Fagan United States · #1,850,042 worldwide 760 citations · 21 works
  3. 3 Thomas W. Bruice United States · #2,129,284 worldwide 1.2k citations · 22 works
  4. 4 Ben Harrison United States · #2,813,370 worldwide 177 citations · 25 works
All ranked researchers at Biota Pharmaceuticals (United States)

What are the most cited papers from Biota Pharmaceuticals (United States)?

The most cited paper from Biota Pharmaceuticals (United States) is "A communal catalogue reveals Earth’s multiscale microbial diversity" (Luke Thompson et al., 2017), with 2,968 citations. Next come "Correlation detection strategies in microbial data sets vary widely in sensitivity and precision" (931) and "Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine" (149).

Most cited papers
#PaperReleasedCitations
1 A communal catalogue reveals Earth’s multiscale microbial diversity Luke Thompson et al. · Nature Open access303 authors 30 Oct 2017 2,968
2 Correlation detection strategies in microbial data sets vary widely in sensitivity and precision Sophie J. Weiss, Will Van Treuren, Catherine Lozupone et al. · The ISME Journal Open access 23 Feb 2016 931
3 Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine Jacob Atsmon, Efrat Kate-Ilovitz, Dimitry Shaikevich et al. · Journal of Clinical Immunology Open access 8 Feb 2012 149
4 Synapsin I is structurally similar to ATP‐utilizing enzymes Lothar Esser, Chyung‐Ru Wang, Masahiro Hosaka et al. · The EMBO Journal Open access 15 Feb 1998 131
5 Resiquimod and other immune response modifiers as vaccine adjuvants Mark A. Tomai, Richard Lloyd Miller, Kenneth E. Lipson et al. · Expert Review of Vaccines Oct 2007 86
All 98 most cited papers, with filters and sorting

Which keywords describe research at Biota Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Antioxidant, Cancer, Oxidative Stress, Inflammation, Data Integration, Regeneration, Targeted Therapy and Gene Expression.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Cancer3▲ 4.6×11 topics
  2. Epidemiology2▲ 1.42×12 topics
  3. Inflammation2▲ 2.7×12 topics
  4. Oxidative Stress2▲ 3.3×12 topics
  5. Antioxidant2▲ 7.5×10 topics
  6. Gene Expression1▲ 5.2×5 topics
  7. Data Integration1▲ 18×2 topics
  8. Innovation1▲ 3.0×2 topics
  9. Clinical Trials1▲ 4.2×7 topics
  10. Immune Response1▲ 5.1×6 topics
  11. Immunotherapy1▲ 4.0×4 topics
  12. Regeneration1▲ 14×3 topics
  13. Targeted Therapy1▲ 12×3 topics
  14. Angiogenesis1▲ 7.5×4 topics
  15. Filaggrin1▲ 50×1 topic
  16. Neurological Disorders1▲ 4.5×4 topics
  17. Pathogenesis1▲ 5.2×4 topics
  18. Skin Microbiome1▲ 50×1 topic
  19. Sustainability1◆ 1.10×7 topics
  20. Circular Economy1▲ 8.6×2 topics
  21. Data Sharing1▲ 73×2 topics
  22. Nutrition1▲ 5.3×3 topics
  23. RNA-Seq1▲ 20×2 topics
  24. SARS-CoV-21▲ 7.7×3 topics

Which research topics does Biota Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Cancer Genomics and Diagnostics, Single-cell and spatial transcriptomics and Genetically Modified Organisms Research.

  1. 1 Dermatology and Skin Diseases Dermatology 1 works
  2. 2 Cancer Genomics and Diagnostics Cancer Research 1 works
  3. 3 Single-cell and spatial transcriptomics Molecular Biology 1 works
  4. 4 Genetically Modified Organisms Research Plant Science 1 works
  5. 5 Research Data Management Practices Information Systems 1 works
  6. 6 Bioeconomy and Sustainability Development General Agricultural and Biological Sciences 1 works
  7. 7 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  8. 8 Trace Elements in Health Nutrition and Dietetics 1 works
  9. 9 Phytochemicals and Medicinal Plants Complementary and alternative medicine 1 works
  10. 10 RNA Research and Splicing Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.4%not open47.6%

World: 40% of research is openly available.

with international co-authors36.0%domestic only64.0%

World: 18% is written across borders.

How has Biota Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 116% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biota Pharmaceuticals (United States) as a percentage of every work published that year, 0.00015% in 2024.

still counting0.00020%0.00040%Biota Pharmaceuticals (United States)0.00026% in 20251990200020102020

Fractional works of Biota Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Alpharetta

All research institutions in Alpharetta

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biota Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.